Discover how PEPperPRINT GmbH services simplify and streamline epitope mapping for both B- and T-cells with this new application note. By seamlessly combining PEPperCHIPĀ® Peptide Microarrays with T-cell activation assays, you will be able to uncover the intricate relationship between these vital components of the immune system. This approach provides an efficient and effective way to map B-cell and T-cell receptor epitopes simultaneously.
Empower your research with a one-stop solution for immune fingerprint alayses. Unlock the future of epitope mapping and explore new horizons in your immunology research.
Anti-Drug Antibodies Use-Case: In response to reported side effects for brolucizumab in 2020, a group of Novartis scientists identified a class-switched, high-affinity immune response against multiple epitopes by anti-brolucizumab antibodies.
T-Cell Services for Cancer Research: Learn how our T-cell services can support your cancer research and the development of cancer immunotherapies. From the validation of neoantigens and the analysis of cytokines to TCR sequencing and more.
Interested in combined B- & T-cell Epitope Mapping? Reach out to our Sciencewerke sales representative at [email protected] or call us at +60 16 220 5131.